← Home
Gradient Dissent · May 26, 2026 · 1h 14m

He Raised $70M to Cure Every Disease With AI

Samuel Rodriques, founder of Edison Scientific, discusses Kosmos, an AI system designed to accelerate drug discovery and cure diseases by automating the scientific process. The conversation covers how AI can propose novel treatments, why human scientists remain essential despite automation, and the structural barriers slowing American drug development.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Novel

AI Scientists Can Propose Novel Drug Candidates
Rodriques built Kosmos, an AI system capable of proposing original drug candidates by automating the scientific hypothesis-generation and testing process.

Highlights

AI Can Map Complex Biological Systems Like the Brain
One of Kosmos's proposed applications is mapping the human brain—an extraordinarily complex task that AI systems are beginning to tackle.

Editorial

Rodriques addresses skepticism about whether AI will replace human scientists in 20 years, implying the answer is no and that humans remain integral to the scientific process.
The show notes reference what's stopping America in drug discovery, suggesting regulatory, organizational, or infrastructure bottlenecks are holding back the field.
Peptide Therapies Are Not Rodriques's Focus
Rodriques states he would never touch a peptide, indicating a deliberate constraint on what types of molecules Kosmos pursues.

Misc

Rodriques left physics because he felt there were no unsolved problems left in the field—a strikingly confident exit.
Edison Scientific raised $70M to build an 'AI scientist' that can propose novel drug candidates.
The episode hints at a specific cure Kosmos proposed for blindness, but details aren't provided in show notes.
Was this useful?